NeoGenomics, Inc. (NEO) vs Teladoc Health, Inc. (TDOC)
A side-by-side comparison of NeoGenomics, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
NEO
NeoGenomics, Inc.
$18.47HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
TDOC
Teladoc Health, Inc.
$5.52HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — NEO vs TDOC
growth of $100 · dividends reinvested · last 10yNEO +119.0% (+8.2%/yr)TDOC -68.2% (-10.8%/yr)NEO compounded faster over this window
Log scale — wide-divergence pair
NEO TDOC
NEO vs TDOC: by the numbers
- •TDOC is the larger company ($1.00B vs $475M market cap).
- •Both run net losses; NEO's is the smaller (-6.77% vs -7.13% net margin).
- •NEO grew revenue faster over the past five years (9.41% vs 8.85% CAGR).
Metrics side by side
Valuation
| Metric | NEO | TDOC |
|---|---|---|
| Forward P/E | 101.08 | N/A |
| P/S ratio | 0.62 | 0.40 |
| P/B ratio | 0.60 | 0.77 |
| EV / EBITDA | N/A | 12.45 |
| FCF yield | N/A | 22.40% |
Profitability
| Metric | NEO | TDOC |
|---|---|---|
| Gross margin | 42.92% | 73.53% |
| Operating margin | -8.63% | -6.98% |
| Net margin | -6.77% | -7.13% |
| ROE | -6.60% | -13.54% |
| ROIC | -5.29% | -7.32% |
Growth (annualized)
| Metric | NEO | TDOC |
|---|---|---|
| Revenue CAGR (5Y) | 9.41% | 8.85% |
| Total return CAGR (5Y) | -18.18% | -46.28% |
Frequently asked
- Which has grown faster, NEO or TDOC?
- Over the past five years, NEO grew revenue faster — NEO at a 9.41% CAGR versus TDOC at 8.85%.
- How have NEO and TDOC total returns compared?
- Over the past 10 years, NEO delivered 8.10% and TDOC delivered -11.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
NeoGenomics ROETeladoc Health ROENeoGenomics operating marginTeladoc Health operating marginNeoGenomics revenue growthTeladoc Health revenue growthNeoGenomics free cash flowTeladoc Health free cash flow
NeoGenomics & Teladoc Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.